On its second bid day, investors are responding favourably to Akums Drugs and Pharmaceuticals’ initial public offering, which comes as the Nity 50 is about to reach 25,000 levels in a bull market. Akums Drugs and Pharmaceuticals IPO subscription status is 4.43 times, according to BSE data. The price band […]
Trending Tags
Sunday, Feb 23, 2025